Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Surface Profiling Of Extracellular Vesicles From Plasma Or Ascites Fluid Using DotScan Antibody Microarrays.

L. Belov, S. Hallal, Kieran J Matic, J. Zhou, S. Wissmueller, N. Ahmed, Sumaiya Tanjil, S. Mulligan, O. Best, R. Simpson, R. Christopherson
Published 2017 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
DotScan antibody microarrays were initially developed for the extensive surface profiling of live leukemia and lymphoma cells. DotScan's diagnostic capability was validated with an extensive clinical trial using mononuclear cells from the blood or bone marrow of leukemia or lymphoma patients. DotScan has also been used for the profiling of surface proteins on peripheral blood mononuclear cells (PBMC) from patients with HIV, liver disease, and stable and progressive B-cell chronic lymphocytic leukemia (CLL). Fluorescence multiplexing allowed the simultaneous profiling of cancer cells and leukocytes from disaggregated colorectal and melanoma tumor biopsies after capture on DotScan. In this chapter, we have used DotScan for the surface profiling of extracellular vesicles (EV) recovered from conditioned growth medium of cancer cell lines and the blood of patients with CLL. The detection of captured EV was performed by enhanced chemiluminescence (ECL) using biotinylated antibodies that recognized antigens expressed on the surface of the EV subset of interest. DotScan was also used to profile EV from the blood of healthy individuals and the ascites fluid of ovarian cancer patients. DotScan binding patterns of EV from human plasma and other body fluids may yield diagnostic or prognostic signatures for monitoring the incidence, treatment, and progression of cancers.
This paper references
10.4049/jimmunol.1402025
Sialylation of N-Linked Glycans Influences the Immunomodulatory Effects of IgM on T Cells
M. Colucci (2015)
10.1084/jem.20091107
Identity of the elusive IgM Fc receptor (FcμR) in humans
H. Kubagawa (2009)
10.1016/j.jim.2010.03.017
An extended antibody microarray for surface profiling metastatic melanoma.
Kimberley Louise Kaufman Alexander-Kaufman (2010)
10.1002/prca.200780090
Stable and unstable angina: Identifying novel markers on circulating leukocytes
A. Brown (2008)
10.1093/jnci/djt048
A new diagnostic tool with the potential to predict tumor metastasis.
J. Nicholas (2013)
10.14670/HH-17.347
Immunohistochemical analysis of beta3 integrin (CD61): expression in pig tissues and human tumors.
A. Meroño (2002)
10.1177/172460089200700307
CEA Serum Levels in Non-Neoplastic Disease
A. R. Morell (1992)
10.1016/j.thromres.2012.02.041
Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.
Jeroen F van Velzen (2012)
10.1091/mbc.E12-08-0572
Extracellular vesicles: communication, coercion, and conditioning
David A. Shifrin (2013)
Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
L. Belov (2001)
10.1002/0471143030.cb0322s30
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
C. Théry (2006)
10.1016/J.YGYNO.2007.08.064
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
S. Runz (2007)
10.1128/IAI.71.8.4767-4771.2003
Nonspecific Immunoglobulin M Binding and Chondroitin Sulfate A Binding Are Linked Phenotypes of Plasmodium falciparum Isolates Implicated in Malaria during Pregnancy
A. Creasey (2003)
10.3402/jev.v2i0.20304
Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress
P. Kucharzewska (2013)
10.1369/jhc.2010.956644
Enhanced Expression of CD13 in Vessels of Inflammatory and Neoplastic Tissues
P. D. Matteo (2011)
10.3402/jev.v2i0.19671
Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis
C. Gardiner (2013)
10.1002/1097-0142(19810315)47:6<1424::AID-CNCR2820470630>3.0.CO;2-O
The relationship of survival to staging and grading of colorectal carcinoma: A prospective study of 503 cases
R. C. Newland (1981)
10.1016/j.canlet.2008.02.006
Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays.
P. Ellmark (2008)
10.1182/asheducation-2008.1.450
Disease-specific complications of chronic lymphocytic leukemia.
C. Dearden (2008)
10.1111/j.1478-3231.2012.02854.x
Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray
W. Rahman (2012)
10.3389/fimmu.2015.00006
Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases
Ana Gámez-Valero (2015)
10.1016/j.clinthera.2014.05.010
Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells.
M. Oksvold (2014)
10.3402/jev.v2i0.20677
Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes
Rossella Crescitelli (2013)
10.1155/2012/971907
Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome
R. C. Lai (2012)
10.2174/1566524011307010058
Tumor-derived microvesicles and the cancer microenvironment.
G. Camussi (2013)
Isolation of prostate cancer-related exosomes.
K. Mizutani (2014)
10.1038/NM1295-1279
Genetic control of the CD4/CD8 T-cell ratio in humans
A. Amadori (1995)
10.1182/BLOOD.V94.11.3791.423A22_3791_3799
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
H. F. G. Heijnen (1999)
10.1016/j.ymeth.2015.04.008
Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
R. Xu (2015)
10.1146/ANNUREV.IMMUNOL.21.120601.141018
B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
N. Chiorazzi (2003)
10.1084/jem.20120833
Cellular origin and pathophysiology of chronic lymphocytic leukemia
M. Seifert (2012)
10.1002/PMIC.200500468
Multiplex detection of surface molecules on colorectal cancers
Peter Ellmark (2006)
10.1007/978-1-61779-286-1_25
Contact printing of protein microarrays.
John Austin (2011)
10.1016/J.AB.2007.07.010
Evaluation of surface chemistries for antibody microarrays.
Shannon L. Seurynck-Servoss (2007)
10.3791/3322
Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing.
J. Zhou (2011)
10.1158/2326-6066.CIR-15-0086
Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade
R. J. Kelleher (2015)
10.1016/j.semcdb.2015.01.013
Extracellular vesicles as modulators of the cancer microenvironment.
J. Webber (2015)
10.1111/j.1749-6632.2012.06517.x
Multifarious roles of sialic acids in immunity
A. Varki (2012)
10.3389/fphys.2012.00354
Alternative Methods for Characterization of Extracellular Vesicles
F. Momen-Heravi (2012)
Proteomic characterisation of chronic lymphocytic leukaemia cells treated with rituximab
M. Alomari (2014)
10.4049/jimmunol.180.12.8146
Induction of Exosome Release in Primary B Cells Stimulated via CD40 and the IL-4 Receptor1
Sarah C Saunderson (2008)
10.1371/journal.pone.0124436
Exosomes Are Unlikely Involved in Intercellular Nef Transfer
X. Luo (2015)
10.3389/fimmu.2014.00442
Tetraspanins in Extracellular Vesicle Formation and Function
Zoraida Andreu (2014)
10.18433/J3F01C
Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes.
Pauline Y. Huang (2013)
10.1158/1055-9965.EPI-11-1093
Prevalidation of Salivary Biomarkers for Oral Cancer Detection
D. Elashoff (2012)
10.1038/bjc.2012.267
Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients
I. Tarantino (2012)
10.1155/2016/6391264
Phenotyping of Leukocytes and Leukocyte-Derived Extracellular Vesicles
L. H. Pugholm (2016)
10.1016/j.bbi.2007.09.001
Total lymphocyte CD8 expression is not a reliable marker of cytotoxic T-cell populations in human peripheral blood following an acute bout of high-intensity exercise
J. P. Campbell (2008)
10.1155/2015/634865
Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype
T. Green (2015)
10.1182/asheducation-2013.1.158
Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers.
T. Shanafelt (2013)
10.1016/j.thromres.2013.11.010
Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube.
B. György (2014)
10.1007/978-94-007-5811-7_15
Antibody Microarrays and Multiplexing
J. Zhou (2013)
10.1016/j.jim.2014.11.001
Surface profiles of live colorectal cancer cells and tumor infiltrating lymphocytes from surgical samples correspond to prognostic categories.
J. Zhou (2015)
10.3402/jev.v3.26913
Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles
J. Lötvall (2014)
10.1016/S0145-2126(98)00154-4
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.
A. Stacchini (1999)
10.1586/14737159.2014.943193
Extracellular vesicles as a platform for ‘liquid biopsy’ in glioblastoma patients
David R. Santiago-Dieppa (2014)
10.1182/BLOOD.V98.12.3383
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.
J. Golay (2001)
10.3324/haematol.2010.030189
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group
S. Molica (2011)
10.3402/jev.v5.25355
Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples
L. Belov (2016)
10.1083/JCB.200508014
Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane
A. Booth (2006)
10.1073/pnas.1418401112
Differential fates of biomolecules delivered to target cells via extracellular vesicles
Masamitsu Kanada (2015)
10.1182/blood-2009-09-242719
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
A. Ghosh (2010)
10.1111/cas.12896
Extracellular vesicle transfer of cancer pathogenic components
Y. Fujita (2016)
10.1016/j.jim.2010.01.015
Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing.
J. Zhou (2010)
10.1074/mcp.M900152-MCP200
Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature*
S. Mathivanan (2009)
10.1007/978-1-59745-188-8_14
The applicability of a cluster of differentiation monoclonal antibody microarray to the diagnosis of human disease.
P. Ellmark (2008)
10.1101/gad.192351.112
Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers.
C. D'Souza-Schorey (2012)
10.1242/jcs.096040
CD98 at the crossroads of adaptive immunity and cancer
Joseph M. Cantor (2012)
10.3322/caac.21208
Cancer statistics, 2014
R. Siegel (2014)
10.1093/jmcb/mjt011
Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells.
J. Cai (2013)
10.3802/jgo.2014.25.4.352
Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients
M. Lee (2014)
10.1097/TP.0000000000000617
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays
W. Rahman (2015)
10.1186/1471-2172-8-12
CD8α is expressed by human monocytes and enhances FcγR-dependent responses
Derrick J. Gibbings (2007)
10.1074/mcp.M400180-MCP200
Optimized Normalization for Antibody Microarrays and Application to Serum-Protein Profiling*S
Darren Hamelinck (2005)
10.3402/jev.v4.26883
Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles
Jinghuan Li (2015)
10.1182/BLOOD-2004-12-4642
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals.
A. Woolfson (2005)
10.1186/1742-4690-4-83
Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages
Jing Qin Wu (2007)
10.1182/blood-2007-06-093906
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
M. Hallek (2008)
10.1007/BF02554593
Staging of colorectal cancer
N. Davis (1984)
10.3389/fonc.2013.00256
Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
N. Ahmed (2013)
10.1093/AJCP/107.1.105
Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.
D. Adcock (1997)
10.17980/2015.208
Cell-derived Extracellular Vesicles Open New Perspectives for Cancer Research
Irène Tatischeff (2015)
10.1371/journal.pone.0005219
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
M. Logozzi (2009)
10.3402/jev.v4.27522
Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis
Taixue An (2015)
10.1002/pmic.201300282
Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma
Hina Kalra (2013)
10.18632/oncotarget.6899
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer
F. Royo (2016)
10.1074/jbc.M504528200
Human Serum IgM Glycosylation
J. N. Arnold (2005)
10.3402/jev.v3.24783
Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum
G. Shelke (2014)
10.1111/j.1365-2141.2006.06266.x
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray
L. Belov (2006)
10.1016/j.thromres.2008.01.005
Isotype controls in phenotyping and quantification of microparticles: a major source of error and how to evade it.
A. Trummer (2008)
10.1016/j.tcb.2015.01.004
Ectosomes and exosomes: shedding the confusion between extracellular vesicles.
Emanuele Cocucci (2015)
10.1371/journal.pbio.0050158
Higher-Order Oligomerization Targets Plasma Membrane Proteins and HIV Gag to Exosomes
Y. Fang (2007)
10.1128/IAI.01217-06
Dendritic Cell-Derived Exosomes Express a Streptococcus pneumoniae Capsular Polysaccharide Type 14 Cross-Reactive Antigen That Induces Protective Immunoglobulin Responses against Pneumococcal Infection in Mice
J. Colino (2006)
10.1186/1742-4690-5-24
Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy
Jing Qin Wu (2007)
10.1111/j.1538-7836.2007.02369.x
Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?
M. Tesselaar (2007)
10.18632/ONCOTARGET.3801
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes
Shivakumar Keerthikumar (2015)
10.1038/sj.bjc.6602316
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects
D. D. Taylor (2005)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar